CareDx (CDNA) General Counsel has 2,873 shares withheld to cover RSU taxes

Rhea-AI Filing Summary

CareDx, Inc. reported a routine insider tax-related transaction by its Secretary and General Counsel, Jeffrey Adam Novack. On May 1, 2026, 2,873 shares of common stock were withheld by the company at $21.50 per share to cover tax obligations arising from the vesting of restricted stock units. After this withholding, Novack directly held 116,612 shares of CareDx common stock. This was a compensation-related tax-withholding event, not an open-market purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Novack Jeffrey Adam

Role Secretary and General Counsel

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	2,873	$21.50	$62K

Holdings After Transaction: Common Stock — 116,612 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares withheld for taxes: 2,873 shares Withholding price: $21.50 per share Shares held after transaction: 116,612 shares +1 more

4 metrics

Shares withheld for taxes 2,873 shares Common stock withheld on May 1, 2026

Withholding price $21.50 per share Value used for tax-withholding shares

Shares held after transaction 116,612 shares Direct common stock holdings after withholding

Tax-withholding shares count 2,873 shares Reported as tax withholding in transaction summary

Key Terms

restricted stock units, tax withholding obligations, Form 4

3 terms

restricted stock units financial

"in connection with the issuance of shares upon the vesting of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"withheld by the Issuer in order to satisfy certain tax withholding obligations"

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Novack Jeffrey Adam

(Last) (First) (Middle)

C/O CAREDX, INC.

8000 MARINA BOULEVARD, 4TH FLOOR

(Street)

BRISBANE CALIFORNIA 94005

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CareDx, Inc. [ CDNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Secretary and General Counsel

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/01/2026		F		2,873(1)	D	$21.5	116,612	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.

	/s/ Jeffrey Adam Novack	05/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did CareDx (CDNA) report for Jeffrey Adam Novack?

CareDx reported a routine tax-related disposition. The company withheld 2,873 shares from Secretary and General Counsel Jeffrey Adam Novack to satisfy tax obligations tied to vesting restricted stock units, rather than an open-market sale or purchase.

Was the CareDx (CDNA) Form 4 transaction an open-market sale of shares?

No, the Form 4 shows no open-market sale. The 2,873 shares were withheld by CareDx to cover tax liabilities from restricted stock unit vesting, a non-market transaction commonly used to satisfy insider tax obligations.

How many CareDx (CDNA) shares does Jeffrey Adam Novack hold after this Form 4?

Following the tax-withholding transaction, Jeffrey Adam Novack directly holds 116,612 shares of CareDx common stock. This figure reflects his position after 2,873 shares were retained by the company for tax obligations on vested restricted stock units.

What was the effective price used for the CareDx (CDNA) tax withholding?

The shares withheld for taxes were valued at $21.50 per share. CareDx used this price when retaining 2,873 shares from Jeffrey Adam Novack to satisfy tax obligations associated with the vesting of restricted stock units.

Does the CareDx (CDNA) Form 4 indicate option exercises or other derivatives?

The Form 4 excerpt shows no derivative exercises. It records only a non-derivative transaction where 2,873 common shares were withheld for tax obligations upon restricted stock unit vesting, with no remaining derivative positions listed in the provided data.